BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14697004)

  • 21. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance characteristics of prostate-specific antigen in patients undergoing radical prostatectomy.
    Liu JJ; Ferrari M; Nolley R; Brooks JD; Presti JC
    Urology; 2012 Jun; 79(6):1336-9. PubMed ID: 22516358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report.
    Klein EA; Chait A; Hafron JM; Kernen KM; Manickam K; Stephenson AJ; Wagner M; Zhu H; Kestranek A; Zaslavsky B; Stovsky M
    Eur Urol; 2017 Dec; 72(6):942-949. PubMed ID: 28396176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A global goodness-of-fit test for receiver operating characteristic curve analysis via the bootstrap method.
    Zou KH; Resnic FS; Talos IF; Goldberg-Zimring D; Bhagwat JG; Haker SJ; Kikinis R; Jolesz FA; Ohno-Machado L
    J Biomed Inform; 2005 Oct; 38(5):395-403. PubMed ID: 16198998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
    Naya Y; Fritsche HA; Cheli CD; Stamey TA; Bartsch G; Brawer MK; Childs S; Taneja SS; Lepor H; Partin AW; Sokoll LJ; Chan DW; Babaian RJ
    Urology; 2003 Dec; 62(6):1058-62. PubMed ID: 14665355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer: relative effects of demographic, clinical, histologic, and MR imaging variables on the accuracy of staging.
    Getty DJ; Seltzer SE; Tempany CM; Pickett RM; Swets JA; McNeil BJ
    Radiology; 1997 Aug; 204(2):471-9. PubMed ID: 9240538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.
    Akin O; Sala E; Moskowitz CS; Kuroiwa K; Ishill NM; Pucar D; Scardino PT; Hricak H
    Radiology; 2006 Jun; 239(3):784-92. PubMed ID: 16569788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Eur Urol; 2004 Nov; 46(5):571-8. PubMed ID: 15474265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bayesian hierarchical non-linear regression model in receiver operating characteristic analysis of clustered continuous diagnostic data.
    Zou KH; O'Malley AJ
    Biom J; 2005 Aug; 47(4):417-27. PubMed ID: 16161801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smooth non-parametric receiver operating characteristic (ROC) curves for continuous diagnostic tests.
    Zou KH; Hall WJ; Shapiro DE
    Stat Med; 1997 Oct; 16(19):2143-56. PubMed ID: 9330425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
    Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
    Bianco FJ; Mallah KN; Korets R; Hricak H; Scardino PT; Kattan MW
    Urology; 2007 Feb; 69(2):343-6. PubMed ID: 17320675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Prostate Cancer Recurrence After Radical Prostatectomy.
    Jeffers A; Sochat V; Kattan MW; Yu C; Melcon E; Yamoah K; Rebbeck TR; Whittemore AS
    Prostate; 2017 Feb; 77(3):291-298. PubMed ID: 27775165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6.
    Song W; Bang SH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Kim CK; Lee HM
    Clin Genitourin Cancer; 2018 Aug; 16(4):281-287. PubMed ID: 29550198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis.
    Taneja SS; Hsu EI; Cheli CD; Walden P; Bartsch G; Horninger W; Babaian RJ; Fritsche HA; Childs S; Stamey TA; Sokoll LJ; Chan DW; Brawer MK; Partin AW; Lepor H
    Urology; 2002 Oct; 60(4 Suppl 1):10-7. PubMed ID: 12384157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating and comparing diagnostic tests' accuracy when the gold standard is not binary.
    Obuchowski NA
    Acad Radiol; 2005 Sep; 12(9):1198-204. PubMed ID: 16099683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.